Efficacy and safety of mavacamten therapy in hypertrophic cardiomyopathy: An up-to-date systematic review and meta-analysis

Back

HFA Premium Access

Efficacy and safety of mavacamten therapy in hypertrophic cardiomyopathy: An up-to-date systematic review and meta-analysis

Session: ePosters in myocardial disease 2

Topic: Hypertrophic Cardiomyopathy

Speaker: Doctor M. Yacoub (Galway, IE)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Magdi Yacoub

National University of Ireland, Galway (Ireland)

0 follower

6 more presentations in this session

Apical hypertrophic cardiomyopathy: is it truly a rare variant?

Speaker: Doctor I. Martins Moreira (Vila Real, PT)

Hypertrophic cardiomyopathy and coronary artery disease: prevalence, characteristics, and implications in the context of evolving physical exercise recommendations

Speaker: Doctor I. Ferreira Neves (Lisboa, PT)

A new model for predicting cardiovascular events in hypertrophic cardiomyopathy: the role of systemic inflammation

Speaker: Doctor I. Miranda (Amadora, PT)

Sex differences in hypertrophic cardiomyopathy

Speaker: Doctor M. Bernardo (Vila Real, PT)

Hypertrophic cardiomyopathy in a tertiary care center, a descriptive study

Speaker: Doctor M. Dankova (Bratislava, SK)

Access the full session

ePosters in myocardial disease 2

Speakers: Doctor M. Yacoub, Doctor I. Martins Moreira, Doctor I. Ferreira Neves, Doctor I. Miranda, Doctor M. Bernardo...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources